title: Reply: Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
authors.affiliation: Nuclear Medicine Department CHRU Besancon 3 bd Fleming Besancon 25000, France E-mail: berthet.louis@free.fr.
authors.forename: Louis
authors.initials: L
authors.lastname: Berthet
authors.forename: Olivier
authors.initials: O
authors.lastname: Humbert
authors.forename: Alexandre
authors.initials: A
authors.lastname: Cochet
mesh_terms: D001853:Bone Marrow / Q000000981:diagnostic imaging* / Q000473:pathology*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000000981:diagnostic imaging* / Q000473:pathology*; D008297:Male; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18